» Articles » PMID: 17400273

Phosphorylation of Hepatitis C Virus NS5A Nonstructural Protein: a New Paradigm for Phosphorylation-dependent Viral RNA Replication?

Overview
Journal Virology
Specialty Microbiology
Date 2007 Apr 3
PMID 17400273
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

The hepatitis C virus (HCV) nonstructural 5A (NS5A) phosphoprotein has been intensely studied due to its ability to subvert the host interferon-induced antiviral response. However, more recent studies suggest that it may also play an important regulatory role in HCV RNA replication as well as modulate host intracellular signaling pathways. Phosphorylation of NS5A appears to be a highly regulated process and several cellular protein kinases responsible for NS5A phosphorylation have been identified in vitro. Studies utilizing the HCV replicon cell culture system have suggested a provocative role for the differential phosphorylation of NS5A in the regulation of viral RNA replication through its association with the viral replication complex, including several host cell factors. Importantly, recent in vivo data linking loss of NS5A hyperphosphorylation to non-productive HCV replication in the chimpanzee model have provided high validation for targeting the cellular kinases involved, particularly the kinases responsible for NS5A phosphorylation, for antiviral therapeutic intervention. Understanding the process of NS5A phosphorylation and the definite identification of the culprit cellular protein kinase(s) will shed light on the mechanisms of HCV RNA replication and/or pathogenesis.

Citing Articles

Anti-viral and Apoptotic Induction of m-TOR Inhibitor Drugs against Hepatitis C Virus Activity and Hepatocellular Carcinoma Cell Line: In vitro and in silico.

Mofed D, Ahmed W, Mohaseb R, Rahouma M, Hassan Ibrahim Faraag A, Sabet S Asian Pac J Cancer Prev. 2024; 25(10):3725-3739.

PMID: 39471041 PMC: 11711332. DOI: 10.31557/APJCP.2024.25.10.3725.


Suppression of Innate Immunity by the Hepatitis C Virus (HCV): Revisiting the Specificity of Host-Virus Interactive Pathways.

Barik S Int J Mol Sci. 2023; 24(22).

PMID: 38003289 PMC: 10671098. DOI: 10.3390/ijms242216100.


ASPP2 binds to hepatitis C virus NS5A protein via an SH3 domain/PxxP motif-mediated interaction and potentiates infection.

Smirnov A, Magri A, Lotz R, Han X, Yin C, Harris M J Gen Virol. 2023; 104(9).

PMID: 37750869 PMC: 7615710. DOI: 10.1099/jgv.0.001895.


Serine-arginine protein kinases and their targets in viral infection and their inhibition.

Zheng K, Ren Z, Wang Y Cell Mol Life Sci. 2023; 80(6):153.

PMID: 37198350 PMC: 10191411. DOI: 10.1007/s00018-023-04808-6.


Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) development.

Ikram A, Rauff B, Alzahrani B, Awan F, Obaid A, Naz A Sci Rep. 2022; 12(1):15648.

PMID: 36123370 PMC: 9483894. DOI: 10.1038/s41598-022-19854-6.